METHOD FOR PREDICTING PROGNOSIS OF PROSTATE CANCER
A method for predicting the prognosis of prostate cancer with high accuracy is disclosed. This method for predicting the prognosis of prostate cancer involves examining at least one single nucleotide polymorphism (SNP) selected from a group comprising rs2891980, rs1805377, rs256550, rs256552, rs256564, rs256563, rs256567, rs1295686, rs20541, rs2162679, rs570730, rs10752126, rs569421 and s2293554 with regard to genomic DNA collected from a prostate cancer patient. The present invention provides, for the first time, a method that enables the prognosis for prostate cancer to be predicted in a highly accurate manner. In particular, in a preferred embodiment, by appropriately combining the abovementioned 14 types of SNPs, the prognosis for prostate cancer can be predicted with far greater accuracy than on the basis of each SNP alone. Furthermore, since a blood sample can be used to make said prediction, there is almost no burden on the patient for testing.